Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutationRezatap ...

John Wiley & Sons, Inc. (NYSE:WLY) Q3 2026 Earnings Call Transcript March 5, 2026 Operator: Good morning, and welcome to John ...

Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...

In Mathematics, there are no shortcuts to understanding, but there are definitely smarter paths to scoring well.

Q1 2026 Earnings Call March 5, 2026 5:00 PM ESTCompany ParticipantsKim Duncan - Vice President of Investor Relations ...